Abeona Therapeutics Inc vs Angi Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Angi Inc trades at $4.55 (market cap $182.30M). The key difference: Abeona Therapeutics Inc is far larger — about 2.3× Angi Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Angi Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ANGI | |
|---|---|---|
Market Cap | $421.19M | $182.30M |
Sector | Health | Media |
52-Week High | $7.45 | $18.46 |
52-Week Low | $4.17 | $4.49 |
Enterprise Value | $276.10M | $392.07M |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →